Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal syndrome characterized by intravascular hemolysis mediated by complement, thrombotic events and alterations in hematopoiesis. Basically, the molecular events which underlie the complexity of the syndrome consist of the absence of the glycosylphosphatidylinositol (GPI) anchor as a consequence of somatic mutations in the PIG-A gene, located on the X chromosome. The GPI group is responsible for the attachment of many proteins to the cytoplasmic membrane. Two of them, CD55 and CD59, have a major role in the inhibition of the action of complement on the cellular membrane of blood cells. The absence of GPI biosynthesis can lead to PNH. Since mutations in the PIG-A gene are always present in patients with PNH, the aim of this study was to characterize the mutations in the PIG-A gene in Brazilian patients. The analysis of the PIG-A gene was performed using DNA samples derived from bone marrow and peripheral blood. Conformation-sensitive gel electrophoresis was used for screening the mutation and sequencing methods were used to identify the mutations. Molecular analysis permitted the identification of three point mutations in three patients: one G-->A transition in the 5' portion of the second intron, one T-->A substitution in the second base of codon 430 (Leu430-->stop), and one deletion DeltaA in the third base of codon 63. This study represents the first description of mutations in the PIG-A gene in a Brazilian population.

Highlights

  • Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal syndrome characterized by intravascular hemolysis mediated by complement, thrombotic events and alterations in hematopoiesis

  • Since mutations in the PIG-A gene are always present in patients with PNH, the aim of this study was to characterize the mutations in the PIG-A gene in Brazilian patients

  • Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hematological syndrome characterized by chronic intravascular hemolysis mediated by complement, thrombotic events and alterations in hematopoiesis [1,2,3]

Read more

Summary

Introduction

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hematological syndrome characterized by chronic intravascular hemolysis mediated by complement, thrombotic events and alterations in hematopoiesis [1,2,3]. The molecular alterations which underlie the complexity of the syndrome are relatively simple [4,5,6,7]. They consist of the absence of the glycosylphosphatidylinositol (GPI) group, responsible for the attachment of several proteins in the cytoplasmic membrane [8], as a consequence of somatic mutations in the PIG-A gene located on the short arm of the X chromosome [9,10]. The GPI group attaches about 20 proteins to the blood cell’s membrane [6]. The absence of GPI biosynthesis can lead to PNH

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call